220 related articles for article (PubMed ID: 29660786)
1. Activity and selectivity cliffs for DPP-IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening.
Ojeda-Montes MJ; Gimeno A; Tomas-Hernández S; Cereto-Massagué A; Beltrán-Debón R; Valls C; Mulero M; Pujadas G; Garcia-Vallvé S
Med Res Rev; 2018 Sep; 38(6):1874-1915. PubMed ID: 29660786
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays.
Guasch L; Ojeda MJ; González-Abuín N; Sala E; Cereto-Massagué A; Mulero M; Valls C; Pinent M; Ardévol A; Garcia-Vallvé S; Pujadas G
PLoS One; 2012; 7(9):e44971. PubMed ID: 22984596
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
Juillerat-Jeanneret L
J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Patel BD; Bhadada SV; Ghate MD
Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
[TBL] [Abstract][Full Text] [Related]
5. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
Li N; Wang LJ; Jiang B; Li XQ; Guo CL; Guo SJ; Shi DY
Eur J Med Chem; 2018 May; 151():145-157. PubMed ID: 29609120
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel dipeptidyl peptidase IV (DPP-IV) inhibitory peptides in camel milk protein hydrolysates.
Nongonierma AB; Paolella S; Mudgil P; Maqsood S; FitzGerald RJ
Food Chem; 2018 Apr; 244():340-348. PubMed ID: 29120791
[TBL] [Abstract][Full Text] [Related]
7. The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitors.
Cox JM; Chu HD; Kuethe JT; Gao YD; Scapin G; Eiermann G; He H; Li X; Lyons KA; Metzger J; Petrov A; Wu JK; Xu S; Sinha-Roy R; Weber AE; Biftu T
Bioorg Med Chem Lett; 2016 Jun; 26(11):2622-6. PubMed ID: 27106708
[TBL] [Abstract][Full Text] [Related]
8. DPP-IV Inhibitory Potentials of Flavonol Glycosides Isolated from the Seeds of
Kim BR; Kim HY; Choi I; Kim JB; Jin CH; Han AR
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103438
[TBL] [Abstract][Full Text] [Related]
9. Novel hydrazine derivatives as selective DPP-IV inhibitors: findings from virtual screening and validation through molecular dynamics simulations.
Tanwar O; Deora GS; Tanwar L; Kumar G; Janardhan S; Alam M; Shaquiquzzaman ; Akhter M
J Mol Model; 2014 Apr; 20(4):2118. PubMed ID: 24687332
[TBL] [Abstract][Full Text] [Related]
10. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.
Meduru H; Wang YT; Tsai JJ; Chen YC
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951
[TBL] [Abstract][Full Text] [Related]
11. Discovery of tight-binding competitive inhibitors of dipeptidyl peptidase IV.
Pascual Alonso I; Valiente PA; Valdés-Tresanco ME; Arrebola Y; Almeida García F; Díaz L; García G; Guirola O; Pastor D; Bergado G; Sánchez B; Charli JL
Int J Biol Macromol; 2022 Jan; 196():120-130. PubMed ID: 34920066
[TBL] [Abstract][Full Text] [Related]
12. Predicting DPP-IV inhibitors with machine learning approaches.
Cai J; Li C; Liu Z; Du J; Ye J; Gu Q; Xu J
J Comput Aided Mol Des; 2017 Apr; 31(4):393-402. PubMed ID: 28155089
[TBL] [Abstract][Full Text] [Related]
13. Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery.
Van der Veken P; Haemers A; Augustyns K
Curr Top Med Chem; 2007; 7(6):621-35. PubMed ID: 17352682
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors.
Liu Y; Si M; Tang L; Shangguan S; Wu H; Li J; Wu P; Ma X; Liu T; Hu Y
Bioorg Med Chem; 2013 Sep; 21(18):5679-87. PubMed ID: 23938053
[TBL] [Abstract][Full Text] [Related]
15. Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors.
Tanwar O; Tanwar L; Shaquiquzzaman M; Alam MM; Akhter M
Bioorg Med Chem Lett; 2014 Aug; 24(15):3447-51. PubMed ID: 24948564
[TBL] [Abstract][Full Text] [Related]
16. Identification of Potential Dipeptidyl Peptidase (DPP)-IV Inhibitors among
Yang Y; Shi CY; Xie J; Dai JH; He SL; Tian Y
Molecules; 2020 Jan; 25(1):. PubMed ID: 31906524
[No Abstract] [Full Text] [Related]
17. Discovery of anthraquinones as DPP-IV inhibitors: Structure-activity relationships and inhibitory mechanism.
Ma HH; Zhang J; Li CQ; Zou LW
Fitoterapia; 2023 Jul; 168():105549. PubMed ID: 37244503
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in non-peptidomimetic dipeptidyl peptidase 4 inhibitors: medicinal chemistry and preclinical aspects.
Liu Y; Hu Y; Liu T
Curr Med Chem; 2012; 19(23):3982-99. PubMed ID: 22709010
[TBL] [Abstract][Full Text] [Related]
19. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening.
Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S
J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572
[TBL] [Abstract][Full Text] [Related]
20. Discovery of triazole-based uracil derivatives bearing amide moieties as novel dipeptidyl peptidase-IV inhibitors.
Deng X; Han L; Zhou J; Zhang H; Li Q
Bioorg Chem; 2017 Dec; 75():357-367. PubMed ID: 29096096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
